PB
Peter Baron Piot
About Peter Baron Piot
Data last updated:
Peter Baron Piot is a Director at Biocon Biologics Limited (since 2021), Additional Director at Biological E. Limited (since 2024) and Director at Biocon Limited (since 2026). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹12,852 Cr; the largest is Biocon Biologics Limited at ₹10,144 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Jan 2021 | 2016 | ₹10,144 Cr (FY 2025) | Active | |
| Additional Director | 27 Nov 2024 | 1953 | ₹2,708 Cr (FY 2024) | Active | |
| Director | 01 Aug 2026 | 1978 | Active |
Board colleagues of Peter Baron Piot
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Peter Baron Piot
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Peter Baron Piot
Peter Baron Piot currently holds 3 directorships: Biocon Biologics Limited (Director, since 21 Jan 2021, revenue ₹10,144 Cr (FY 2025)); Biological E. Limited (Additional Director, since 27 Nov 2024, revenue ₹2,708 Cr (FY 2024)); Biocon Limited (Director, since 01 Aug 2026).
Peter Baron Piot was first appointed on 21 Jan 2021 as Director at Biocon Biologics Limited. The most recent appointment on record is 01 Aug 2026 at Biocon Limited.
The 2 current companies of Peter Baron Piot that report revenue have a combined latest revenue of ₹12,852 Cr: Biocon Biologics Limited ₹10,144 Cr (FY 2025); Biological E. Limited ₹2,708 Cr (FY 2024).
The current boards of Peter Baron Piot's companies include Akhilesh Nand (Biocon Biologics Limited), Arun Suresh Chandavarkar (Biocon Biologics Limited), Bobby Kanubhai Parikh (Biocon Biologics Limited), Daniel Mark Bradbury (Biocon Biologics Limited), Kiran Mazumdar Shaw (Biocon Biologics Limited), Mr. Kedar Upadhye (Biocon Biologics Limited), among others.